Cerium (Ce 3? )-doped monoclinic X 1 -Y 2 SiO 5 (YSO)-type oxyorthosilicates powders were prepared by monomer and polymer-assisted sol-gel method. The present work aims to study the influence of ethylene glycol (EG) monomer, polyethylene glycol (PEG) polymer and polyvinyl alcohol (PVA) polymer, as fuels and nucleating agents for the crystallization, on structural and luminescence properties of the Ce 3? (xCe = 0.01)-doped Y 2 SiO 5 . The X-ray diffraction technique, field emission scanning electron microscopy, Fourier transform infrared spectroscopy and steady photoluminescence have been used to characterize the samples. It is found that the types of fuels affect the phase purity and luminescent characteristics of phosphors. All samples exhibit intense violet-blue asymmetric emission band in the range of 370-540 nm with a maximum intensity centered at around 420 nm assigned to the 5d ? 4f (2F5/2, 2F7/2) interconfigurational transitions of Ce 3? ion in YSO nanomaterial. Finally, the vibronic coupling parameters are estimated and discussed.
An efficient in situ condensation of citronellal, the main constituent of Eucalyptus citriodora essential oil (51%), with different amine derivatives of 2,3diaminomaleonitrile and 3-[(2-aminoaryl)amino]dimedone has led to novel chiral benzodiazepine structures. All reactions were precipitated in ethanol and pure products were obtained in good yields (58%-75%) without any purification. The synthesized benezodiazepines were characterized by spectroscopic techniques, namely 1 H and 13 C-NMR, 2D NMR and FTIR. Differential Scanning Calorimetry (DSC) and HPLC were used to confirm the formation diastereomeric mixtures of benzodiazepine derivatives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.